Tag: hematology
New Interferon Treatment Shows Promise for Essential Thrombocythemia Across All Genetic Variants
New North American study shows ropeginterferon alfa-2b-njft achieved 61% complete response rate in essential thrombocythemia patients across all genetic variants.…
Multiple Myeloma Treatment Paradigm Shift: New Guidelines Redefine Early Relapse
New England Journal of Medicine editorial calls for fundamental changes to multiple myeloma early relapse definitions, arguing biological markers should…
Submit Your Paper to GMJ
No APC until January 2027.

